Literature DB >> 11596606

From the Centers for Disease Control and Prevention. Update: Fatal and severe liver injuries associated with Rifampin and Pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11596606

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Adverse events associated with treatment of latent tuberculosis in the general population.

Authors:  Benjamin M Smith; Kevin Schwartzman; Gillian Bartlett; Dick Menzies
Journal:  CMAJ       Date:  2011-01-10       Impact factor: 8.262

Review 2.  Updates on the risk factors for latent tuberculosis reactivation and their managements.

Authors:  Jing-Wen Ai; Qiao-Ling Ruan; Qi-Hui Liu; Wen-Hong Zhang
Journal:  Emerg Microbes Infect       Date:  2016-02-03       Impact factor: 7.163

3.  The Characteristics, Prevalence, and Risk Factors of Drug-Induced Liver Injury Among Brucellosis Inpatients in Xinjiang, China.

Authors:  Maermaer Tuohutaerbieke; Xinjie Li; Yue Yin; Wei Chen; Dongmei Wu; Zhize Mao; Jiamixi Mamuerjiang; Yimin Mao; Tao Shen
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.